Global Next Generation Sequencing (NGS) Informatics Market, 2021 and 2022-2032

DUBLIN, Feb. 01, 2023 (GLOBE NEWSWIRE) — “NGS Informatics Market – Global and Regional Analysis: Focus on Products and Services, Applications, End Users and Regions – Analysis and Forecasts, 2022-2032” Report has been published.add to

of ResearchAndMarkets.com

Recruitment.

The global NGS informatics market is valued at $1.38 billion in 2021 and is projected to reach $6.715 billion by the end of 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.

The market is driven by factors such as low cost of sequencing platforms, increasing clinical application of NGS in oncology for clinical management of cancer patients and mutational profiling, significant increase in amount of genomic data, and increasing importance. being towed. Population genomics research and the establishment of various biobanks, advances in big data technology, and government initiatives to support NGS advances are expected to drive demand for NGS informatics software.

Market life cycle stages

The global NGS informatics market is in a developing stage. The evolving regulatory environment for clinical NGS and increasing genetic mutations across various diseases are some of the major opportunities in the global NGS informatics market.

Impact of COVID-19

NGS can be used to sequence the genome of an unknown organism. As such, it was widely performed in laboratories during the COVID-19 pandemic.

Studies using NGS sequencing are being conducted in several countries around the world, including countries in emerging regions such as Latin America, the Middle East, and Africa. Initiatives such as the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES) program by the Centers for Disease Control and Prevention (CDC) have also been implemented to facilitate SARS-CoV-sequencing. I was. 2 Virus using NGS technology. Moreover, the emergence of the COVID-19 pandemic has expanded the applications of NGS.

As a result, the company has also developed an NGS solution for genome surveillance of the SARS-CoV-2 virus. Prior to the COVID-19 pandemic, NGS technology was used specifically for clinical diagnosis of cancer and other chronic diseases. The outbreak of the COVID-19 pandemic has accelerated research into using NGS to sequence unknown variants of the SARS-CoV-2 virus.

market segmentation

Products and Services: The global NGS informatics market (by products and services) is expected to be dominated by the commercial data analysis tools, interpretation, and reporting tools segment.

Applications: The global NGS informatics market (by application) is expected to be dominated by the genetic screening segment.

End Users: The global NGS informatics market (by end users) is dominated by the pharmaceutical and biotech companies segment.

Region: The global NGS informatics market (by region) is dominated by the North America region.

Recent developments in the global NGS informatics market

• In August 2022, Thermo Fisher Scientific Inc. launched CE-IVD (IVDD) NGS testing and analysis software, expanding access to precision oncology biomarket testing.

• In June 2022, Thermo Fisher Scientific received the CE-IVD mark for its NGS aneuploidy diagnostic software workflow.

Overview of Key Market Players and Competition

Companies profiled are selected based on information gathered from leading experts and analyzed for company coverage, product portfolio and market penetration.

Some well-known names that have established themselves in this market are:

• Abbott Laboratories

• Agilent Technologies, Inc.

• Azenta Co., Ltd.

• BGI Genomics Inc.

• Denexus Inc.

• eagle genomics

• uformatics

• F. Hoffmann La Roche

• Jenaris BV

• Illumina Inc.

• Paltec Co., Ltd.

• perkinelmer company

• Presigen Co., Ltd.

• Qiagen NV

• Sophia Genetics SA

• Thermo Fisher Scientific

Companies that are not part of the aforementioned pools are, where applicable, well-represented in various sections of the report.

Main indicators

Main topics:

1 market


1.1 Global Market Outlook

1.1.1 Product definition

1.1.2 Inclusion and exclusion criteria

1.1.3 Main Findings

1.1.4 Assumptions and Limitations

1.2 Industry Outlook

1.2.1 Market Overview

1.2.1.1 Introduction

1.2.1.2 Evolution of NGS technology

1.2.1.3 NGS Informatics Market Workflow

1.2.1.4 Market Potential

1.2.2 Legal requirements and framework

1.2.2.1 US legal requirements and framework

1.2.2.1.1 US Food and Drug Administration (FDA)

1.2.2.2 European legal requirements and frameworks

1.2.2.2.1 European Medicines Agency (EMA)

1.2.2.3 Legal requirements and frameworks in Asia Pacific

1.2.2.3.1 China

1.2.2.3.1.1 National Medicines Administration (NMPA)

1.2.2.3.2 Japan

1.2.2.3.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)

1.2.3 Main trends

1.2.3.1 Growing adoption of cloud-based solutions that can easily store large amounts of NGS data

1.2.3.2 Expanding automation of NGS workflow sample/library preparation using NGS informatics

1.2.3.3 Increasing use of NGS in clinical trials to select suitable candidates

1.2.3.4 Remarkably high representation of European candidates in large-scale genomic studies

1.2.4 Opportunity assessment

1.2.5 Cost of NGS data storage in the cloud

1.2.6 Product Benchmark

1.2.7 Patent Analysis

1.2.8 Market value chain

1.3 Impact of COVID-19 on the Global NGS Informatics Market

1.3.1 Implications for NGS research related to the SARS-CoV-2 virus

1.3.2 Influence of Market Parties on New Product Launch

1.3.3 Comparison of pre-, during- and post-COVID-19 scenarios

1.4 Business dynamics

1.4.1 Impact analysis

1.4.2 Business Drivers

1.4.2.1 Low-cost sequencing platforms are increasing public access to NGS tests and driving adoption of NGS informatics solutions.

1.4.2.2 The increasing clinical application of NGS in the field of oncology for the clinical management of cancer patients, followed by mutation profiling to identify treatment options, has increased the demand for NGS.

1.4.2.3 The vast increase in the amount of genomic data has facilitated the adoption of NGS informatics solutions for easy analysis of the data, as well as its storage and computation.

1.4.2.4 The increasing importance of population genomics research and the establishment of various biobanks have led to extensive research worldwide and accelerated research and development in the field of genomics.

1.4.2.5 Advances in big data technology will improve storage and management of NGS data, increase demand for NGS, and drive adoption of NGS software.

1.4.2.6 Demand for NGS informatics software is expected to increase due to government initiatives to support the advancement of NGS.

1.4.3 Business Restrictions

1.4.3.1 Privacy issues are expected to lead to data privacy concerns among the public and discourage participation in NGS research.

1.4.3.2 The lack of trained clinical personnel to conduct NGS experiments and perform data analysis is expected to hinder adoption of NGS software.

1.4.3.3 Low reimbursement rates for NGS worldwide are expected to lead to a lack of interest in NGS and hinder adoption of NGS software and services.

1.4.4 Business Opportunities

1.4.4.1 Evolving regulatory environment for clinical NGS

1.4.4.2 Increased gene mutations in various diseases

2 Global NGS Informatics Market (By Product and Service)


2.1 Opportunity assessment

2.2 Commercial data analysis, data interpretation and reporting tools

2.3 Storage and computing tools

2.4 Laboratory Information Management System (LIMS)

2.5 NGS informatics services

3 Global NGS Informatics Market (By Application)


3.1 Opportunity assessment

3.2 Drug discovery

3.3 Genetic screening

3.4 Disease diagnosis

3.5 Miscellaneous

4 Global NGS Informatics Market (By End User)


4.1 Opportunity assessment

4.2 Hospitals and clinics

4.3 Pharmaceutical and biotech companies

4.4 Academic and research institutions

For more information on this report, please visit https://www.researchandmarkets.com/r/9svhky-informatics?w=12.

About ResearchAndMarkets.com


ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.

• Global NGS informatics market

CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900